Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Jade Biosciences, Inc. | 226,875 | reported | 12 Feb 2026 | tx 3+790,688 |
| Cartesian Therapeutics, Inc. | 38,000 | reported | 04 Jan 2021 | tx 5+848,000 |
| Theseus Pharmaceuticals, Inc. | 0 | reported | 14 Feb 2024 | tx 8+275,972.23−357,764.23 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2026 | GRANT_AWARD | Jade Biosciences, Inc. | 37,813 | 0.00 USD | |
| 12 Feb 2026 | GRANT_AWARD | Jade Biosciences, Inc. | 226,875 | 0.00 USD | deriv |
| 14 Jul 2025 | GRANT_AWARD | Jade Biosciences, Inc. | 526,000 | 0.00 USD | deriv |
| 14 Feb 2024 | TENDER | Theseus Pharmaceuticals, Inc. | 8,150.23 | — | |
| 14 Feb 2024 | OTHER | Theseus Pharmaceuticals, Inc. | 332,114 | — | deriv |
| 14 Feb 2024 | OTHER | Theseus Pharmaceuticals, Inc. | 17,500 | — | deriv |
| 01 Mar 2023 | GRANT_AWARD | Theseus Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 17 Feb 2023 | GRANT_AWARD | Theseus Pharmaceuticals, Inc. | 105,000 | 0.00 USD | deriv |
| 30 Nov 2022 | PURCHASE | Theseus Pharmaceuticals, Inc. | 1,502.19 | 6.66 USD | |
| 18 Feb 2022 | GRANT_AWARD | Theseus Pharmaceuticals, Inc. | 150,000 | 0.00 USD | deriv |
| 21 Dec 2021 | PURCHASE | Theseus Pharmaceuticals, Inc. | 1,970.04 | 10.15 USD | |
| 04 Jan 2021 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 38,000 | 0.00 USD | |
| 04 Jan 2021 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 230,000 | 0.00 USD | deriv |
| 01 Jul 2020 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 02 Jan 2020 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 140,000 | 0.00 USD | deriv |
| 03 Sept 2019 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 400,000 | 0.00 USD | deriv |